Evaluation of risk factors in patients with vulvovaginal candidiasis and the value of chromID Candida agar versus CHROMagar Candida for recovery and presumptive identification of vaginal yeast species

References

• Nyirjesy P, Sobel JD. Vulvovaginal candidiasis. Obstet Gynecol Clin North Am 2003; 30: 671–684.
   PubMedGoogle Scholar
• Goldacre MJ, Watt B, Loudon N, . Vaginal microbial flora in normal young women. Br Med J 1979; 1: 1450–1453.
   PubMed Web of Science ®Google Scholar
• Sobel JD. Vulvaginal candidiasis. Lancet 2007; 369: 1961–1971.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Faro AS, Force RV, . Vulvovaginal candidiasis: epidemiologic, diagnostic and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203–211.
   PubMed Web of Science ®Google Scholar
• Nyirjesy P, Seeney SM, Grody MHT, Jordan CA, Buckley HR. Chronic fungal vaginitis: the value of cultures. Am J Obstet Gynecol 1995; 173: 820–823.
   PubMed Web of Science ®Google Scholar
• Chatwani AJ, Mehta R, Hassan S, . Rapid testing for vaginal yeast detection: a prospective study. Am J Obstet Gynecol 2007; 196: 309–310.
   PubMed Web of Science ®Google Scholar
• Pincus DH, Orenga S, Chatellier S. Yeast identification: past, present, and future methods. Med Mycol 2007; 45: 97–121.
   PubMed Web of Science ®Google Scholar
• Freydiére AM, Guinet R, Boiron P. Yeast identification in the clinical microbiology laboratory: phenotypical methods. Med Mycol 2001; 39: 9–33.
   PubMed Web of Science ®Google Scholar
• Ozcan K, Ilkit M, Ates A, Turaç–Biçer A, Demirhindi H. Performance of Chromogenic Candida agar and CHROMagar Candida in recovery and presumptive identification of monofungal and polyfungal vaginal isolates. Med Mycol 2010; 48: 29–34.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Vazquez JA. Symptomatic vulvovaginitis due to fluconazole–resistant Candida albicans in a female who was not infected with human immunodeficiency virus. Clin Infect Dis 1996; 22: 726–727.
   PubMed Web of Science ®Google Scholar
• Eraso E, Moragues MD, Villar–Vidal M, . Evaluation of the new chromogenic medium Candida ID2 for isolation and identification of Candida albicans and other medically important Candida species. J Clin Microbiol 2006; 44: 3340–3345.
   PubMed Web of Science ®Google Scholar
• Eraso E, Sahand ID, Villar–Vidal M, . Usefulness of Candida ID2 agar for the presumptive identification of Candida dubliniensis. Med Mycol 2006; 44: 611–615.
   PubMed Web of Science ®Google Scholar
• Willinger B, Hillowoth C, Selitsch B, Manafi M. Performance of Candida ID, a new chromogenic medium for presumptive identification of Candida species, in comparison to CHROMagar Candida. J Clin Microbiol 2001; 39: 3793–3795.
   PubMedGoogle Scholar
• Fricker–Hidalgo H, Orenga S, Lebeau B, . Evaluation of Candida ID, a new chromogenic medium for fungal isolation and preliminary identification of some yeast species. J Clin Microbiol 2001; 39: 1647–1649.
   PubMedGoogle Scholar
• Odds FC, Bernaerts R. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species. J Clin Microbiol 1994; 32: 1923–1929.
   PubMed Web of Science ®Google Scholar
• Beighton D, Ludford R, Clark DT, . Use of CHROMagar Candida medium for isolation of yeasts from dental samples. J Clin Microbiol 1995; 33: 3025–3027.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Houston A, Coffmann S. Application of CHROMagar Candida for rapid screening of clinical specimens for Candida albicans, Candida tropicalis, Candida krusei, and Candida (Torulopsis) glabrata. J Clin Microbiol 1996; 34: 58–61.
   PubMed Web of Science ®Google Scholar
• Bouchara JP, Declerck P, Cimon B, . Routine use of CHROMagar Candida medium for presumptive identification of Candida yeast species and detection of mixed polyfungal populations. Clin Microbiol Infect 1996; 2: 202–208.
   PubMedGoogle Scholar
• Anson JJ, Allen KD. Evaluation of CHROMagar Candida medium for the isolation and direct identification of yeast species from the female genitale tract. Br J Biomed Sci 1997; 54: 237–239.
   PubMedGoogle Scholar
• Willinger B, Manafi M. Evaluation of CHROMagar Candida for rapid screening of clinical specimens for Candida species. Mycoses 1999; 42: 61–65.
   PubMed Web of Science ®Google Scholar
• Hospenthal DR, Beckius ML, Floyd KL, Horvath LL, Murray KK. Presumptive identification of Candida species other than C. albicans, C. krusei, and C. tropicalis with the chromogenic medium CHROMagar Candida. Ann Clin Microbiol Antimicrob 2006; 5: 1.
   PubMedGoogle Scholar
• Buckley HR. Identification of yeasts. Evans EGV, Richardson MD. Medical Mycology: A Practical Approach. Oxford: IRL Press. 1989: 97–109.
   Google Scholar
• Pinjon E, Sullivan D, Salkin I, Shanley D, Coleman D. Simple, inexpensive, reliable method for differentiation of Candida dubliniensis from Candida albicans. J Clin Microbiol 1998; 36: 2093–2095.
   PubMed Web of Science ®Google Scholar
• Donders GG, Prenen H, Verbeke G, Reybrouck R. Impaired tolerance for glucose in women with recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 2002; 187: 989–993.
   PubMedGoogle Scholar
• Nickerson WJ. Reduction of inorganic substances by yeasts. I. Extracellular reduction of sulfite by species of Candida. J Infect Dis 1953; 93: 45–56.
   Google Scholar
• Pagano J, Levine JD, Trejo W. Diagnostic medium for differentiation of species of Candida. Antibiot Ann 1957–1958; 5:137–143.
   PubMedGoogle Scholar
• Spinillo A, Capuzzo E, Gulminetti R, . Prevalence of and risk factors for fungal vaginitis caused by non–albicans species. Am J Obstet Gynecol 1997; 176: 138–141.
   PubMed Web of Science ®Google Scholar
• Richter SS, Galask RP, Messer SA, . Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases. J Clin Microbiol 2005; 43: 2155–2162.
   PubMed Web of Science ®Google Scholar
• Sobel JD, Chaim W. Treatment of Torulopsis glabrata vaginitis: a retrospective review of boric acid therapy. Clin Infect Dis 1997; 24: 649–652.
   PubMed Web of Science ®Google Scholar
• Donders GG, Mertens I, Bellen G, Pelckmans S. Self–elimination of risk factors for recurrent vaginal candidosis. Mycoses DOI: 10.1111/j.1439–0507.2009.01754.
   Google Scholar
• Pirotta MV, Gunn JM, Chondros P. ‘Not thrush again!’ Women's experience of post–antibiotic vulvovaginitis. Med J Aust 2003; 179: 43–46.
   PubMed Web of Science ®Google Scholar
• Bluestein D, Rutledge C, Lumsden L. Predicting the occurrence of antibiotic–induced candidal vaginitis (AICV). Fam Pract Res J 1991; 11: 319–326.
   PubMedGoogle Scholar
• Glover DD, Larsen B. Relationship of fungal vaginitis therapy to prior antibiotic exposure. Infect Dis Obstet Gynecol 2003; 11: 157–160.
   PubMedGoogle Scholar